Report overview
This report contains market size and forecasts of Molecular Diagnostics in Point of Care in Global, including the following market information:
Global Molecular Diagnostics in Point of Care Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Molecular Diagnostics in Point of Care market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Polymerase Chain Reaction Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnostics in Point of Care include Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter, Becton, Dickinson and Company, Binx Health, Biocartis, bioM?rieux and Bio-Rad Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Diagnostics in Point of Care companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnostics in Point of Care Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Molecular Diagnostics in Point of Care Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Global Molecular Diagnostics in Point of Care Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Molecular Diagnostics in Point of Care Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Independent Clinical Laboratories
Global Molecular Diagnostics in Point of Care Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Molecular Diagnostics in Point of Care Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnostics in Point of Care revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Molecular Diagnostics in Point of Care revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton, Dickinson and Company
Binx Health
Biocartis
bioM?rieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
